Considering Proximal Urea Cycle Disorders in Expanded Newborn Screening
Open Access
- 8 October 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Neonatal Screening
- Vol. 6 (4), 77
- https://doi.org/10.3390/ijns6040077
Abstract
Proximal urea cycle disorders (PUCDs) have adverse outcomes such as intellectual disability and death, which may benefit from newborn screening (NBS) through early detection and prevention with early treatment. Ornithine transcarbamylase deficiency (OTCD) and carbamoyl phosphate synthetase 1 deficiency (CPS1D) are screened in six and eight states in the United States. We analyzed current evidence to see if it supports inclusion of PUCDs in the NBS panels based upon prevention potential, medical, diagnostic, treatment, and public health rationales. A literature review was performed in PubMed using MESH terms for OTCD, CPS1D, and NAGSD. A systematic review was performed in the hallmark of NBS inclusion criteria. We reviewed 31 articles. Molecular and biochemical diagnosis is available to provide diagnostic evidence. Untreated PUCDs have a significant burden with considerable developmental delay and mortality that may improve with early treatment. Tandem mass spectrometry can be used for NBS for PUCDs; however, citrulline and glutamine alone are not specific. Medical treatments currently available for PUCDs meet existing medical, diagnostic, treatment, and public health rationales. Improvement in NBS algorithms to increase sensitivity and specificity will allow earlier diagnosis and treatment to potentially improve disability and mortality rates.Keywords
This publication has 36 references indexed in Scilit:
- The incidence of urea cycle disordersMolecular Genetics and Metabolism, 2013
- Liver transplantation for urea cycle disorders in pediatric patients: A single‐center experiencePediatric Transplantation, 2013
- Suggested guidelines for the diagnosis and management of urea cycle disordersOrphanet Journal of Rare Diseases, 2012
- Long‐term outcome and intervention of urea cycle disorders in JapanJournal of Inherited Metabolic Disease, 2011
- Hypocitrullinemia in expanded newborn screening by LC–MS/MS is not a reliable marker for ornithine transcarbamylase deficiencyJournal of Pharmaceutical and Biomedical Analysis, 2009
- Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21‐year, multicentre study of acute hyperammonaemic episodesActa Paediatrica, 2008
- A review of the psychosocial effects of false‐positive results on parents and current communication practices in newborn screeningJournal of Inherited Metabolic Disease, 2006
- From Public Health Emergency to Public Health Service: The Implications of Evolving Criteria for Newborn Screening PanelsPEDIATRICS, 2006
- Current role of liver transplantation for the treatment of urea cycle disorders: A review of the worldwide English literature and 13 cases at Kyoto UniversityLiver Transplantation, 2005
- Urea cycle defects: Management and outcomeJournal of Inherited Metabolic Disease, 2005